Bill Texts: NY A03253 | 2021-2022 | General Assembly

Bill Title: Requires manufacturer of nonprescription blood glucose self-testing equipment, devices and supplies to submit to the New York State Board of Pharmacy a comprehensive list of designated suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies; prohibits pharmacists from distributing nonprescription blood glucose self-testing equipment, devices, and supplies or seeking reimbursement therefor when the pharmacist knows or has reason to know that the equipment did not come through an authorized supplier or distributor.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2022-01-05 - referred to higher education [A03253 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2021-01-22HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New York A03253

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New York A03253 currently on file.

Social Comments on NY A03253

feedback